Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alzheimer's disease
Pharma
Eisai's push toward blockbuster Leqembi sales gains steam
The company doubled sales of its Biogen-partnered Alzheimer's disease treatment during its 2025 fiscal year.
Zoey Becker
May 15, 2026 11:35am
BMS-Hengrui, Takeda layoffs, Daiichi—Fierce Pharma Asia
May 15, 2026 8:30am
Axsome increases Auvelity's peak sales projection to $8B
May 5, 2026 11:48am
Anti-amyloid Alzheimer's drugs show 'trivial' effects: report
Apr 16, 2026 11:36am
Cognito partners with nonprofit to drop the term ‘dementia’
Apr 8, 2026 10:11am
Fosun looks to revive Green Valley's embattled Alzheimer's med
Dec 16, 2025 1:36am
